You are here: Home » PTI Stories » National » News
Business Standard

CMFRI develops nutraceutical product to combat hypertension

Topics
Health Medical Pharma

Press Trust of India  |  Kochi 

In a major development in utilising the medicinal prospects of marine organisms, the Central Marine Fisheries Research Institute has now come up with a nutraceutical product from sea to combat hypertension.

The product, CadalminTM Antihypertensive extract (CadalminTM AHe), was developed from seaweeds, which are commonly available in the Indian coastal waters and are known for their extraordinary medicinal properties, a CMFRI release said here Tuesday.

"Bioactive pharmacophore leads from seaweeds were used to develop this product, which can be administered orally to regulate hypertension that is one of the risk factors for strokes, heart attacks, heart failure, and arterial aneurysm, and is a leading cause of chronic kidney failure," it said.

This is sixth in the series of the nutraceutical products developed by CMFRI.

The institute has already developed and commercialised natural products for diseases such as diabetes, arthritis, cholesterol and hypothyroid.

Dr Trilochan Mohapatra, Secretary, Department of Agriculture Research and Education and Director General of Indian Council of Agricultural Research (ICAR) released the product at a function held at CMFRI last week.

"The extract contains 100 per cent natural marine bioactive ingredients from selected seaweeds by a patented technology, and would be made available in 400 mg capsules," said Kajal Chakraborty, senior scientist at CMFRI who developed the product.

"This nutraceutical does not have any side-effects as established by detailed preclinical trials. CadalminTM Antihypertensive extract is the only product made by 100 per cent natural marine bioactive ingredients from seaweeds as a natural remedy of hypertension," the scientist added.

Dr A Gopalakrishnan, Director, ICAR-CMFRI said entrepreneurs and start-ups were welcome to upscale and market this product by expression of interest (EOI) with CMFRI.

The institute is in the process of developing more health products from the underutilised seaweeds, he said adding "efforts are on for standardising and promoting seaweed farming all along the Indian coasts as a livelihood option for the coastal communities."

This was expected to compensate for the dip in income for the fishermen during lean seasons," Gopalakrishnan said.

Dr J K Jena, DDG (Fisheries), ICAR, presided over the function.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, May 28 2019. 17:00 IST
RECOMMENDED FOR YOU